What is the current Cardiac Point-of-Care (POCs) market size?

The Cardiac Point-of-Care (POCs) market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Cardiac POCs market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Cardiac Point-of-Care (POCs) market?

Key drivers include rising cardiovascular disease prevalence and growing demand for portable diagnostic devices.

What are the major challenges facing the Cardiac POCs market?

Challenges include high development costs and stringent regulatory requirements for new products.

Which regions are leading the Cardiac Point-of-Care (POCs) market?

North America and Europe are currently the leading regions, driven by advanced healthcare infrastructure.

Who are the top companies in the Cardiac POCs market?

Top companies include Abbott, Roche, and Siemens Healthineers, offering a range of diagnostic solutions.

What future opportunities exist in the Cardiac Point-of-Care (POCs) market?

Future opportunities include emerging markets and innovative technologies, such as AI-powered diagnostic devices.

How is technology impacting the Cardiac POCs market?

Technology is driving growth through advancements in portable and wireless diagnostic devices, improving patient outcomes.

What is the current regulatory landscape for the Cardiac Point-of-Care (POCs) market?

The regulatory landscape is evolving, with a focus on ensuring device safety and efficacy through rigorous testing.

What is the future outlook for the Cardiac POCs market?

The future outlook is positive, with increasing demand for point-of-care diagnostics driving market growth and innovation.

Cardiac Point-of-Care (POCs) - Strategic Insights: Analysis 2025 and Forecasts 2033

Cardiac Point-of-Care (POCs) by Application (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), by Types (Blood Tests Including Cholesterol, Coagulation Testing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 75

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 75

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Cardiac Point-of-Care (POCs) Market Overview

The Cardiac Point-of-Care (POCs) market refers to the industry that provides medical devices and technologies for the diagnosis and monitoring of cardiovascular diseases at the point of care. As the Cardiac Point-of-Care (POCs) market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant industry expansion driven by the increasing prevalence of cardiovascular diseases and the need for rapid diagnosis and treatment. The scope of the market includes handheld devices, mobile devices, and other portable equipment used for cardiac monitoring, diagnosis, and treatment, also known as point-of-care testing or POCT. The current Cardiac Point-of-Care (POCs) market size is approximately $1.1 billion, with a growth forecast of 7.3% Compound Annual Growth Rate (CAGR) from 2026 to 2033, driven by macro drivers such as technological advancements, regulatory approvals, and changing consumer behavior.

Loading chart…

The key forces shaping the Cardiac Point-of-Care (POCs) market include technology shifts towards wireless and mobile devices, regulatory approvals for new products, and changing consumer behavior towards home-based care. The largest region for the Cardiac Point-of-Care (POCs) market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and growing demand for point-of-care devices. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, opportunities, and challenges in the Cardiac Point-of-Care (POCs) market.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	25.88 million
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Abbott; Roche Diagnostics; Boston Scientific; Medtronic
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cardiac Point-of-Care (POCs) market is poised for significant growth, driven by factors that are reshaping the healthcare landscape. Understanding the dynamics of this market is crucial for stakeholders seeking to capitalize on emerging trends and opportunities.

Growth Drivers2 items

Advancements in technology, such as the development of portable and user-friendly Cardiac Point-of-Care (POCs) devices, are expanding the reach of cardiac care services, contributing to the growth of the Cardiac Point-of-Care (POCs) market size.

Increasing demand for rapid and accurate diagnostic testing, particularly in remote or underserved areas, is driving the adoption of Cardiac Point-of-Care (POCs) solutions, thereby influencing the growth forecast of the market.

Restraints2 items

High development costs associated with Cardiac Point-of-Care (POCs) devices, including the expense of meeting stringent regulatory requirements, can limit the entry of new manufacturers into the market, potentially constraining the Cardiac Point-of-Care (POCs) market size.

Concerns regarding the accuracy and reliability of Cardiac Point-of-Care (POCs) tests, compared to traditional laboratory-based diagnostic methods, may hinder widespread adoption and impact the growth forecast.

Opportunities2 items

The integration of artificial intelligence and machine learning into Cardiac Point-of-Care (POCs) devices presents opportunities for enhanced diagnostic capabilities and personalized patient care, potentially expanding the Cardiac Point-of-Care (POCs) market.

Partnerships between Cardiac Point-of-Care (POCs) manufacturers and healthcare providers can facilitate the development of tailored solutions, addressing specific clinical needs and driving market growth.

Challenges2 items

Ensuring the security and privacy of patient data, particularly in the context of wireless Cardiac Point-of-Care (POCs) devices, poses a significant challenge that must be addressed through robust data protection measures.

Maintaining a balance between the cost of Cardiac Point-of-Care (POCs) devices and their accuracy and reliability is crucial for manufacturers seeking to penetrate the market and contribute to its growth forecast.

Market Segmentation

Loading chart…

The Application segment in the Cardiac Point-of-Care (POCs) market plays a crucial role in determining the overall market size. This segment is divided into subtypes, including troponin, CK-MB, myoglobin, and BNP. Each subtype contributes to the market size by catering to different cardiac conditions, such as myocardial infarction, heart failure, and coronary artery disease. Understanding the Cardiac Point-of-Care (POCs) segmentation is essential to identify the target audience and develop effective marketing strategies. The application segment accounts for a significant share of the market, driven by the increasing prevalence of cardiac diseases and the need for rapid diagnosis and treatment.

The Types segment in the Cardiac Point-of-Care (POCs) market is another critical factor that influences the market size. This segment includes subtypes such as laboratory-based, hospital-based, and home-based testing. Each subtype has its own set of advantages and disadvantages, and the market size is affected by the adoption rate of these testing methods. The market taxonomy of the Cardiac Point-of-Care (POCs) market is complex, and understanding the types segment is vital to navigate the market landscape. The types segment is expected to grow significantly, driven by the increasing demand for point-of-care testing and the development of innovative testing technologies.

Cardiac Point-of-Care (POCs) Segmentation Breakdown7 items

Application

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Types

Blood Tests Including Cholesterol

Coagulation Testing

Regional Insights

Loading chart…

The Cardiac Point-of-Care (POCs) market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of POCs, favorable policies, and significant investments in healthcare infrastructure.

In North America, key drivers include high demographics of cardiovascular diseases, advanced infrastructure, and a mature ecosystem. Europe is driven by policies supporting the use of POCs, a high level of adoption among healthcare providers, and significant investments in research and development. Asia Pacific's growth is fueled by large demographics, increasing adoption of POCs, and growing investments in healthcare. Latin America and Middle East & Africa are driven by improving infrastructure, increasing adoption, and government policies supporting the use of POCs.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the increasing demand for cardiac POCs and the growing ecosystem maturity. The Cardiac Point-of-Care (POCs) market is expected to continue growing, driven by the increasing need for rapid and accurate diagnosis of cardiovascular diseases.

Competitive Landscape

The Cardiac Point-of-Care (POCs) competitive landscape is moderately consolidated, with a mix of global players and local companies driving the market. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals, which enable companies to differentiate themselves in a high competition environment. The market structure is characterized by a balance between global players, such as major diagnostics companies, and local/regional companies, which focus on specific regions or product lines, influencing the Cardiac Point-of-Care (POCs) key players.

Companies in the Cardiac Point-of-Care (POCs) market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks, which require them to adapt their strategies to stay competitive.

Abbott Laboratories: regional expansion

Roche Diagnostics: innovation pipeline

Boston Scientific: premium pricing

Medtronic: vertical integration

Abbott: OEM tie-ups

Roche: local manufacturing

Key Cardiac Point-of-Care (POCs) Companies5 items

Abbott Laboratories

Abbott

Roche Diagnostics

Boston Scientific

Medtronic

Market Ecosystem

The Cardiac Point-of-Care (POCs) ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream channels and end users. Value is created and captured as these participants interact, driving the development, integration, and deployment of POC solutions. The ecosystem can be broadly segmented into three main stages: upstream, where technology and components are developed; midstream, where integrators and manufacturers create POC products; and downstream, where channels and end users interact.

Technology providers — develop core POC technologies

OEMs / manufacturers — produce POC devices and systems

System integrators / EPCs — integrate POC solutions with existing infrastructure

Distributors / channel partners — supply POC products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce POC standards and regulations

End users / buyers — utilize POC solutions in clinical settings

In the Cardiac Point-of-Care (POCs) ecosystem, control points are primarily held by regulators and standards bodies, as well as large OEMs and technology providers, who influence adoption through their development of core technologies and products. Dependency risks arise from input constraints, such as component availability, and standards and approvals, which can delay or limit the deployment of POC solutions. Furthermore, switching costs and interoperability requirements can create barriers to entry for new participants, while partnerships and collaborations can facilitate the development of integrated POC solutions. As the ecosystem differs by region, due to varying regulatory environments and healthcare systems, participants must adapt their strategies to navigate these diverse landscapes and capture value in the Cardiac Point-of-Care (POCs) value chain analysis.

Recent Industry Insights

The Cardiac Point-of-Care (POCs) industry trends have witnessed significant developments over the last 12-18 months, transforming the landscape of the industry. Recent partnerships, such as the collaboration between leading diagnostic companies, have enabled the creation of innovative products and services. Additionally, strategic mergers and acquisitions have led to the expansion of product portfolios and increased market share. Several companies have also launched new products and technologies, including advanced diagnostic devices and artificial intelligence-powered monitoring systems.

Furthermore, regulatory changes have paved the way for the adoption of point-of-care devices, and a shift in consumer trends has led to increased demand for personalized and portable cardiac care solutions. The industry has also seen significant funding rounds and expansions, with investors backing companies that develop innovative cardiac point-of-care solutions. These developments are expected to drive growth in the Cardiac Point-of-Care (POCs) market, shaping the future of cardiac care.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Cardiac Point-of-Care (POCs) market outlook. The market attractiveness is high due to the increasing prevalence of cardiovascular diseases and the growing demand for rapid and accurate diagnostic testing. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios. The long-term outlook is positive, driven by advancements in technology and the rising adoption of point-of-care testing in cardiac care.

The innovation landscape is characterized by the development of portable and user-friendly devices, enabling healthcare professionals to diagnose and monitor cardiac conditions effectively. The demand-supply balance is expected to be stable, with manufacturers addressing the growing demand for cardiac POCs. However, key risk factors include regulatory challenges and intense competition, which may impact market growth. Overall, the Cardiac Point-of-Care (POCs) market outlook is favorable, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Cardiac Point-of-Care (POCs) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cardiac Point-of-Care (POCs) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cardiac Point-of-Care (POCs) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Cardiac Centers

6.1.3. Ambulatory Surgical Centers

6.2. Global Cardiac Point-of-Care (POCs) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Tests Including Cholesterol

6.2.2. Coagulation Testing

6.3. Global Cardiac Point-of-Care (POCs) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cardiac Point-of-Care (POCs) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cardiac Point-of-Care (POCs) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cardiac Point-of-Care (POCs) Market Competition by Key Manufacturers

8.1. Global Cardiac Point-of-Care (POCs) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cardiac Point-of-Care (POCs): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Roche Diagnostics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Boston Scientific

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Medtronic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cardiac Point-of-Care (POCs) Market

Figure 4: Global Cardiac Point-of-Care (POCs) Market: Drivers

Figure 5: Global Cardiac Point-of-Care (POCs) Market: Challenges

Figure 6: Global Cardiac Point-of-Care (POCs) Market: Trends

Figure 7: Global Cardiac Point-of-Care (POCs) Market: Opportunity

Figure 8: Global Cardiac Point-of-Care (POCs) Market: Restraint

Figure 9: Global Cardiac Point-of-Care (POCs) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cardiac Point-of-Care (POCs) Market Value (USD Million) By Region

Figure 15: Global Cardiac Point-of-Care (POCs) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cardiac Point-of-Care (POCs) Market Value (USD Million) By Region

Figure 23: Global Cardiac Point-of-Care (POCs) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

63 items

Table 1: Market Segmentation Analysis

Table 2: Global Cardiac Point-of-Care (POCs) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cardiac Point-of-Care (POCs) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cardiac Point-of-Care (POCs) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cardiac Point-of-Care (POCs) Market Value (USD Million) By Region

Table 10: Global Cardiac Point-of-Care (POCs) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cardiac Point-of-Care (POCs) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cardiac Point-of-Care (POCs) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cardiac Point-of-Care (POCs) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: Abbott Basic Information And Sales Area

Table 33: Abbott. Products Portfolio

Table 34: Roche Diagnostics Basic Information And Sales Area

Table 35: Roche Diagnostics. Products Portfolio

Table 36: Boston Scientific Basic Information And Sales Area

Table 37: Boston Scientific. Products Portfolio

Table 38: Medtronic Basic Information And Sales Area

Table 39: Medtronic. Products Portfolio

Table 40: Global Market Value (USD Million) (2025-2032) By Application

Table 41: Global Market Share (%) By Application (2032)

Table 42: Global Market Value (USD Million) (2025-2032) By Types

Table 43: Global Market Share (%) By Types (2032)

Table 44: Global Cardiac Point-of-Care (POCs) Market Value (USD Million) By Region

Table 45: Global Cardiac Point-of-Care (POCs) Market Share (%) By Region (2025-2032)

Table 46: North America Market Value (USD Million) (2025-2032) By Country

Table 47: North America Market Value (USD Million) (2025-2032) By Application

Table 48: North America Market Value (USD Million) (2025-2032) By Types

Table 49: Europe Market Value (USD Million) (2025-2032) By Country

Table 50: Europe Market Value (USD Million) (2025-2032) By Application

Table 51: Europe Market Value (USD Million) (2025-2032) By Types

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 53: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 55: South America Market Value (USD Million) (2025-2032) By Country

Table 56: South America Market Value (USD Million) (2025-2032) By Application

Table 57: South America Market Value (USD Million) (2025-2032) By Types

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 59: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 61: Research Programs/Design For This Report

Table 62: Key Data Information From Secondary Sources

Table 63: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Cardiac Point-of-Care (POCs) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	25.88 million
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Abbott; Roche Diagnostics; Boston Scientific; Medtronic
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Cardiac Point-of-Care (POCs) Segmentation Breakdown7 items

Application

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Types

Blood Tests Including Cholesterol

Coagulation Testing

Regional Insights

Loading chart…

Competitive Landscape

Abbott Laboratories: regional expansion

Roche Diagnostics: innovation pipeline

Boston Scientific: premium pricing

Medtronic: vertical integration

Abbott: OEM tie-ups

Roche: local manufacturing

Key Cardiac Point-of-Care (POCs) Companies5 items

Abbott Laboratories

Abbott

Roche Diagnostics

Boston Scientific

Medtronic

Market Ecosystem

Technology providers — develop core POC technologies

OEMs / manufacturers — produce POC devices and systems

System integrators / EPCs — integrate POC solutions with existing infrastructure

Distributors / channel partners — supply POC products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce POC standards and regulations

End users / buyers — utilize POC solutions in clinical settings

Recent Industry Insights

Analyst Overview

Table of Contents